Meaningfully, as above mentioned, immunolabeling for cathepsin K is observed in approximately half of TFE3-rearranged renal cell carcinomas, the neoplasm most confused with clear cell renal cell carcinomas and papillary renal cell carcinoma [66]. This evidence concerns the gene CTSK and clear cell renal carcinoma.